Search Results - "Rajbhandari, Rajani"

Refine Results
  1. 1

    PERK-Dependent Activation of JAK1 and STAT3 Contributes to Endoplasmic Reticulum Stress-Induced Inflammation by Meares, Gordon P., Liu, Yudong, Rajbhandari, Rajani, Qin, Hongwei, Nozell, Susan E., Mobley, James A., Corbett, John A., Benveniste, Etty N.

    Published in Molecular and cellular biology (01-10-2014)
    “…Neuroinflammation and endoplasmic reticulum (ER) stress are associated with many neurological diseases. Here, we have examined the interaction between ER…”
    Get full text
    Journal Article
  2. 2
  3. 3

    NF-κB-induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma by McFarland, Braden C, Hong, Suk W, Rajbhandari, Rajani, Twitty, Jr, George B, Gray, G Kenneth, Yu, Hao, Benveniste, Etty N, Nozell, Susan E

    Published in PloS one (11-11-2013)
    “…Glioblastoma (GBM) is the most aggressive, neurologically destructive and deadly tumor of the central nervous system (CNS). In GBM, the transcription factors…”
    Get full text
    Journal Article
  4. 4

    Let-7 Status Is Crucial for PARP1 Expression in HER2-Overexpressing Breast Tumors by Wielgos, Monica E, Rajbhandari, Rajani, Cooper, Tiffiny S, Wei, Shi, Nozell, Susan, Yang, Eddy S

    Published in Molecular cancer research (01-03-2017)
    “…HER2 breast tumors have been shown to express elevated levels of PARP1 protein. Yet, the mechanism by which PARP1 is upregulated in HER2 breast cancer is…”
    Get full text
    Journal Article
  5. 5

    Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer by Nair, Sindhu, Trummell, Hoa Q, Rajbhandari, Rajani, Thudi, Nanda K, Nozell, Susan E, Warram, Jason M, Willey, Christopher D, Yang, Eddy S, Placzek, William J, Bonner, James A, Bredel, Markus

    Published in PloS one (18-02-2020)
    “…Epidermal growth factor receptor (EGFR) is a pro-tumorigenic receptor tyrosine kinase that facilitates growth for cancer cells that overexpress the receptor…”
    Get full text
    Journal Article
  6. 6

    The Chinese Pueraria root extract (Pueraria lobata) ameliorates impaired glucose and lipid metabolism in obese mice by Prasain, Jeevan K., Peng, Ning, Rajbhandari, Rajani, Wyss, J. Michael

    Published in Phytomedicine (Stuttgart) (15-12-2012)
    “…The incidence of type 2 diabetes and metabolic disease is rapidly increasing, but effective therapies for their prevention and treatment have been poorly…”
    Get full text
    Journal Article
  7. 7

    Trastuzumab-Resistant HER2 + Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition by Wielgos, Monica E, Zhang, Zhuo, Rajbhandari, Rajani, Cooper, Tiffiny S, Zeng, Ling, Forero, Andres, Esteva, Francisco J, Osborne, C Kent, Schiff, Rachel, LoBuglio, Albert F, Nozell, Susan E, Yang, Eddy S

    Published in Molecular cancer therapeutics (01-05-2018)
    “…HER2-targeted therapies, such as trastuzumab, have increased the survival rates of HER2 breast cancer patients. However, despite these therapies, many tumors…”
    Get full text
    Journal Article
  8. 8

    MicroRNA‐31 is required for astrocyte specification by Meares, Gordon P., Rajbhandari, Rajani, Gerigk, Magda, Tien, Chih‐Liang, Chang, Chenbei, Fehling, Samuel C., Rowse, Amber, Mulhern, Kayln C., Nair, Sindhu, Gray, G. Kenneth, Berbari, Nicolas F., Bredel, Markus, Benveniste, Etty N., Nozell, Susan E.

    Published in Glia (01-05-2018)
    “…Previously, we determined microRNA‐31 (miR‐31) is a noncoding tumor suppressive gene frequently deleted in glioblastoma (GBM); miR‐31 suppresses tumor growth,…”
    Get full text
    Journal Article
  9. 9

    CSIG-31. ANNEXIN A7 ALTERNATIVE SPLICING IN GLIOMA STEM CELLS FACILITATES THE DEGRADATION OF EGFR BY PHOSPHORYLATING TYROSINE RESIDUES EXCLUSIVE TO PROTEIN ISOFORM 1 by Merati, Aran, Nair, Sindhu, Rajbhandari, Rajani, Johnson, Nicholas, Bredel, Markus

    Published in Neuro-oncology (Charlottesville, Va.) (11-11-2024)
    “…Abstract The majority of GBMs express aberrant receptor tyrosine kinase (RTK) activity, which are canonically endocytosed and degraded. This process is…”
    Get full text
    Journal Article
  10. 10

    Abstract 2445: Alternative splicing dictates receptor tyrosine kinase fates in glioblastoma by Nair, Sindhu, Rajbhandari, Rajani, Hurt, Centdrika, Bredel, Markus

    Published in Cancer research (Chicago, Ill.) (01-07-2021)
    “…Abstract Receptor tyrosine kinase (RTK) genes are frequently amplified and/or overexpressed in glioblastoma (GBM). RTK signaling can undergo two fates -…”
    Get full text
    Journal Article
  11. 11

    COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies by Reder, Anthony T., Centonze, Diego, Naylor, Maria L., Nagpal, Anjali, Rajbhandari, Rajani, Altincatal, Arman, Kim, Michelle, Berdofe, Aaron, Radhakrishnan, Maha, Jung, Eunice, Sandrock, Alfred W., Smirnakis, Karen, Popescu, Catrinel, de Moor, Carl

    Published in CNS drugs (01-03-2021)
    “…Background Disease-modifying therapies (DMTs) for multiple sclerosis (MS) target immunity and have the potential to increase the risk of severe acute…”
    Get full text
    Journal Article
  12. 12

    Abstract 3747: Dysregulated splicing of Annexin A7 impairs receptor tyrosine kinase trafficking in glioblastoma by Nair, Sindhu, Rajbhandari, Rajani, Dates-Hurt, Centdrika, Bredel, Markus

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Abstract Alternative splicing (AS), a tightly regulated process, contributes to proteome diversification essential for tissue development and identity. During…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Abstract 3003: Exon skipping for the tumor suppressor Annexin A7 promotes EGFR signaling in stem-like brain tumor initiating cells through receptor recycling by Merati, Aran, Nair, Sindhu, Rajbhandari, Rajani, Johnson, Nicholas, Bredel, Markus

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Abstract Background: Glioblastoma (GBM) is one of the most lethal forms of cancer. The majority of GBMs express aberrant receptor tyrosine kinase (RTK)…”
    Get full text
    Journal Article
  15. 15

    Abstract 3758: Impact of ANXA7 I1 expression on PDGFRA and MET endosomal trafficking in glioblastoma by White, Zachary B., Hurt, Centdrika Dates, Rajbhandari, Rajani, Nair, Sindhu, Nozell, Susan, Bredel, Markus

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Abstract Purpose/Objective(s): Glioblastomas (GBM) are highly malignant tumors that arise from astrocytes. GBMs rely on signaling through receptor tyrosine…”
    Get full text
    Journal Article
  16. 16

    Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms by Royston, Kendra J., Paul, Bidisha, Nozell, Susan, Rajbhandari, Rajani, Tollefsbol, Trygve O.

    Published in Experimental cell research (01-07-2018)
    “…Little is known about the effects of combinatorial dietary compounds on the regulation of epigenetic mechanisms involved in breast cancer prevention. The human…”
    Get full text
    Journal Article
  17. 17

    CSIG-12. ANNEXIN A7 ISOFORMS DIFFERENTIALLY REGULATE TUMORIGENIC EGFR SIGNALING IN GLIOBLASTOMA MULTIFORME by Nair, Sindhu, Nozell, Susan, Hurt, Centdrika, Rajbhandari, Rajani, Bredel, Markus

    Published in Neuro-oncology (Charlottesville, Va.) (05-11-2018)
    “…Abstract Dysregulation of receptor tyrosine kinase genes is a frequent genetic abnormality in GBM. A common genetic alteration is amplification and/or…”
    Get full text
    Journal Article
  18. 18

    STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE by McWilliams, Ian L, Rajbhandari, Rajani, Nozell, Susan, Benveniste, Etty, Harrington, Laurie E

    Published in Journal of neuroinflammation (30-06-2015)
    “…In experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis, mice genetically deficient in the transcription factor signal…”
    Get full text
    Journal Article
  19. 19

    Abstract 471: HER2 regulates PARP-1 expression by suppressing the let-7a microRNA in HER2+ breast cancer by Yang, Eddy Shih-Hsin, Wielgos, Monicka, Rajbhandari, Rajani, Wei, Shi, Nozell, Susan

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Abstract Background: HER2+ breast cancers are sensitive to PARP inhibition and express elevated levels of the PARP-1 protein. However, the mode of regulation…”
    Get full text
    Journal Article
  20. 20

    STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE (BA4P.140) by Harrington, Laurie, Nozell, Susan, Rajbhandari, Rajani, Benveniste, Etty, McWilliams, Ian

    Published in The Journal of immunology (1950) (01-05-2015)
    “…Abstract Factors mediating Th1 and Th17 CD4 T cell driven autoimmunity remain unclear. In the mouse model of Multiple Sclerosis, experimental autoimmune…”
    Get full text
    Journal Article